0L8

Lantheus Holdings Inc

Healthcare · EUR · F

0L8

Price

€80.848

-1.18%

Cap

€6.06B

Earnings

30d Trend

+17.1%

0L8
Loading chart data...
0 days · % change from startPowered by Brain47
VolatilityModerate

37% annualised over 90 days

BRAIN47 SIGNAL

0
STRONG
Risk Level70
Quality76
Momentum65
Technical64
Fundamentals60

Raw weighted: 62×Macro 0.99 (1%)=61

RISK

70/100
90d Volatility
36.9%High
ATR %
3.6%High daily moves
Max Drawdown (1Y)
-40.2%Volatile

QUALITY

76/100
ROE (avg)
21.4%Excellent
Piotroski F-Score
9/9Strong
Debt/Equity
0.52Moderate
Margin Stability
CV 16.8%Volatile
Accruals
-7.0%Cash earnings
Interest Coverage
15.5xVery comfortable

MOMENTUM

65/100
12-1M Momentum
+9.2%Uptrend
6-1M Momentum
+46.5%Positive
1M Return
+22.7%Strong recent gains
Relative Strength
-0.2% vs sectorIn-line

TECHNICAL

64/100
RSI (14)
65.5Neutral
Price vs SMA200
+47.7%Bullish trend
MACD
+0.29Bullish momentum
Bollinger Band
80%Mid-range
SMA Cross
Death CrossDeath Cross
Trend Quality (KER)
0.450Mixed

FUNDAMENTALS

60/100
EV/EBIT
18.1Fair
P/S
3.5Fair
Shareholder Yield
5.5%Strong returns

Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 100%

Running historical backtest...

BRAIN47 HORIZON ANALYSIS

<3 months66
3-12 months79
1-5+ years66

6-9 month momentum thesis — strong trend with confirmation

BRAIN47'S ASSESSMENT

I rate Lantheus Holdings Inc at 61/100 — a STRONG reading on the Brain47 Signal. The strongest factor is quality at 76/100. I classify this as a growth position with the strongest thesis on a medium-term horizon.

PAST PERFORMANCE

1 MONTH

+22.7%

3 MONTHS

+33.0%

12 MONTHS

+31.9%

Trailing returns — past performance, not a projection.

DETAILED ANALYSIS

6-9 month momentum thesis — strong trend with confirmation. Quality (76) and Momentum (65) are the primary strengths. I note an elevated risk profile — this warrants closer monitoring. Historical volatility is moderate at 37%. I classify this as a growth position — strong momentum combined with solid fundamentals points to capital appreciation.

growthScore: 61/100

Want full analysis on every stock?

Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.

Join Brain47 — Free

Generated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.